Rivian Automotive, Inc. R&D increased by 8.0% to $458.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 20.2%, from $381.00M to $458.00M. Over 4 years (FY 2021 to FY 2025), R&D shows relatively stable performance with a -2.6% CAGR.
Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.
Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...
Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.
research_and_development| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $394.00M | $441.00M | $726.00M | $547.00M | $543.00M | $452.00M | $402.00M | $496.00M | $444.00M | $529.00M | $526.00M | $461.00M | $428.00M | $350.00M | $374.00M | $381.00M | $410.00M | $453.00M | $424.00M | $458.00M |
| QoQ Change | — | +11.9% | +64.6% | -24.7% | -0.7% | -16.8% | -11.1% | +23.4% | -10.5% | +19.1% | -0.6% | -12.4% | -7.2% | -18.2% | +6.9% | +1.9% | +7.6% | +10.5% | -6.4% | +8.0% |
| YoY Change | — | — | — | — | +37.8% | +2.5% | -44.6% | -9.3% | -18.2% | +17.0% | +30.8% | -7.1% | -3.6% | -33.8% | -28.9% | -17.4% | -4.2% | +29.4% | +13.4% | +20.2% |